TY - JOUR
T1 - Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24
AU - Chiriva-Internati, Maurizio
AU - Liu, Yong
AU - Weidanz, Jon A.
AU - Grizzi, Fabio
AU - You, Hong
AU - Zhou, Weiping
AU - Bumm, Klaus
AU - Barlogie, Barthel
AU - Mehta, Jawahar L.
AU - Hermonat, Paul L.
PY - 2003/11/1
Y1 - 2003/11/1
N2 - Recent studies demonstrate that recombinant adeno-associated virus (rAAV)-based antigen loading of dendritic cells (DCs) generates significant and rapid (one stimulation per week) cytotoxic T-lymphocyte (CTL) responses in vitro against viral antigens. As a more extensive analysis of the rAAV system, we have used a self-antigen, HM1.24, expressed in multiple myeloma (MM). Again, with one stimulation, significant major histocompatibility complex (MHC) class 1-restricted, anti-HM1.24-specific CTL killing was demonstrated against MM cells. Furthermore, higher expression of interferon-γ (IFN-γ) in T cells and higher expression levels of, in order of significance, CD80 (2.6- to 3.8-fold increase), CD86, and CD40 on DCs were also observed. The use of synthetic HM1.24-positive target cells further demonstrated the antigen specificity of these CTLs. There was also no evidence of natural killer cell involvement. These data extend our earlier studies and suggest that the rAAV-Ioading of DCs may be a particularly good protocol for generating CTLs against self-antigens, which may not otherwise be considered good targets because of their low immunogenicity. We also show that HM1.24 may be an effective antigen for targeting MM.
AB - Recent studies demonstrate that recombinant adeno-associated virus (rAAV)-based antigen loading of dendritic cells (DCs) generates significant and rapid (one stimulation per week) cytotoxic T-lymphocyte (CTL) responses in vitro against viral antigens. As a more extensive analysis of the rAAV system, we have used a self-antigen, HM1.24, expressed in multiple myeloma (MM). Again, with one stimulation, significant major histocompatibility complex (MHC) class 1-restricted, anti-HM1.24-specific CTL killing was demonstrated against MM cells. Furthermore, higher expression of interferon-γ (IFN-γ) in T cells and higher expression levels of, in order of significance, CD80 (2.6- to 3.8-fold increase), CD86, and CD40 on DCs were also observed. The use of synthetic HM1.24-positive target cells further demonstrated the antigen specificity of these CTLs. There was also no evidence of natural killer cell involvement. These data extend our earlier studies and suggest that the rAAV-Ioading of DCs may be a particularly good protocol for generating CTLs against self-antigens, which may not otherwise be considered good targets because of their low immunogenicity. We also show that HM1.24 may be an effective antigen for targeting MM.
UR - http://www.scopus.com/inward/record.url?scp=0142245614&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142245614&partnerID=8YFLogxK
U2 - 10.1182/blood-2002-11-3580
DO - 10.1182/blood-2002-11-3580
M3 - Article
C2 - 12855576
AN - SCOPUS:0142245614
SN - 0006-4971
VL - 102
SP - 3100
EP - 3107
JO - Blood
JF - Blood
IS - 9
ER -